UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Safety and immunogenicity of an MF59® -adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age

Vaccine, 2015-01, Vol.33 (1), p.174-181

2015

Link zum Volltext

Verfügbarkeit prüfen

Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011

Vaccine, 2014-11, Vol.32 (49), p.6622-6630

2014

Link zum Volltext

Verfügbarkeit prüfen

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

BMC infectious diseases, 2013-07, Vol.13 (1), p.348-348, Article 348

2013

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6–35 Months of Age

The Pediatric infectious disease journal, 2014-12, Vol.33 (12), p.e320-e329

2014

Link zum Volltext

Verfügbarkeit prüfen

Implementation of a Q fever vaccination program for high-risk patients in the Netherlands

Vaccine, 2013-05, Vol.31 (23), p.2617-2622

2013

Link zum Volltext

Verfügbarkeit prüfen

Immunization of Early Adolescent Females with Human Papillomavirus Type 16 and 18 L1 Virus-Like Particle Vaccine Containing AS04 Adjuvant

Journal of adolescent health, 2007-06, Vol.40 (6), p.564-571

2007

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules

Human vaccines & immunotherapeutics, 2013-04, Vol.9 (4), p.858-864

2013

Link zum Volltext

Verfügbarkeit prüfen

Specific Interferon γ Detection for the Diagnosis of Previous Q Fever

Clinical infectious diseases, 2013-06, Vol.56 (12), p.1742-1751

2013

Link zum Volltext

Verfügbarkeit prüfen

Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination

The Pediatric infectious disease journal, 2017-09, Vol.36 (9), p.e223-e229

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial

Vaccine, 2008-05, Vol.26 (19), p.2378-2388

2008

Link zum Volltext

Verfügbarkeit prüfen

The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey

BMC infectious diseases, 2011-11, Vol.11 (1), p.320-320, Article 320

2011

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Meningococcal Serogroup B Infections in Children: A Protein-Based Vaccine Induces Immunologic Memory

The Journal of infectious diseases, 2001-07, Vol.184 (1), p.98-102

2001

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age

Vaccine, 2000-02, Vol.18 (15), p.1456-1466

2000

Link zum Volltext

Verfügbarkeit prüfen

Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study

BMJ (Online), 1998-03, Vol.316 (7135), p.902

International edition, 1998

Link zum Volltext

Verfügbarkeit prüfen

Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands

Vaccine, 2004-09, Vol.22 (25), p.3256-3257

2004

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-Induced Antibody Responses as Parameters of the Influence of Endogenous and Environmental Factors

Environmental health perspectives, 2001-08, Vol.109 (8), p.757-764

2001

Link zum Volltext

Verfügbarkeit prüfen

Diphtheria: a 'forgotten' disease?

Nederlands tijdschrift voor geneeskunde, 2019-10, Vol.163

2019

Link zum Volltext

Verfügbarkeit prüfen

Specific Interferon [gamma] Detection for the Diagnosis of Previous Q Fever

Clinical infectious diseases, 2013-06, Vol.56 (12), p.1742

2013

Link zum Volltext

Verfügbarkeit prüfen

Combination vaccine against invasive meningococcal b and pneumococcal infections : Potential epidemiological and economic impact in the Netherlands

PharmacoEconomics, 2006-01, Vol.24 (2), p.141-153

2006

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model

BMC public health, 2011-06, Vol.11 (1), p.462-462, Article 462

2011

Link zum Volltext

Verfügbarkeit prüfen

Reported adverse events following influenza vaccination

Nederlands tijdschrift voor geneeskunde, 2014, Vol.158, p.A6841

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations

Vaccine, 2000-12, Vol.19 (9-10), p.1141-1148

2000

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of monovalent P1.7h, 4 meningococcal outer membrane vesicle vaccine in toddlers : comparison of two vaccination schedules and two vaccine formulations

Vaccine, 2000-12, Vol.19 (9-10), p.1141-1148

2000

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of monovalent P1.7 h,4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations

Vaccine, 2000, Vol.19 (9), p.1141-1148

2000

Link zum Volltext

Verfügbarkeit prüfen

Vaccination against chickenpox, shingles and rotavirus-infection

Nederlands tijdschrift voor geneeskunde, 2009, Vol.153, p.A913

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(33)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(29)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Female
(17)
Immunology
(16)
Infectious Diseases
(16)
Male
(16)
Biological And Medical Sciences
(15)
Child, Preschool
(13)
Medical Sciences
(12)
Medicine, Research & Experimental
(11)
Research & Experimental Medicine
(11)
Vaccines
(11)
Vaccination
(10)
Child
(9)
Fundamental And Applied Biological Sciences. Psychology
(9)
Immunization
(9)
Microbiology
(9)
Infant
(8)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and immunogenicity of an MF59® -adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age

Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6–35 Months of Age

Implementation of a Q fever vaccination program for high-risk patients in the Netherlands

Immunization of Early Adolescent Females with Human Papillomavirus Type 16 and 18 L1 Virus-Like Particle Vaccine Containing AS04 Adjuvant

Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules

Specific Interferon γ Detection for the Diagnosis of Previous Q Fever

Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial

The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey

Prevention of Meningococcal Serogroup B Infections in Children: A Protein-Based Vaccine Induces Immunologic Memory

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age

Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study

Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands

Vaccine-Induced Antibody Responses as Parameters of the Influence of Endogenous and Environmental Factors

Diphtheria: a 'forgotten' disease?

Specific Interferon [gamma] Detection for the Diagnosis of Previous Q Fever

Combination vaccine against invasive meningococcal b and pneumococcal infections : Potential epidemiological and economic impact in the Netherlands

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model

Reported adverse events following influenza vaccination

Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations

Immunogenicity and safety of monovalent P1.7h, 4 meningococcal outer membrane vesicle vaccine in toddlers : comparison of two vaccination schedules and two vaccine formulations

Immunogenicity and safety of monovalent P1.7 h,4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations

Vaccination against chickenpox, shingles and rotavirus-infection

Suchergebnisse filtern